Spike protein induced the generation of IL-6 in cultured cells as well as in COVID-19 positive patient sera, and AT1 receptor antagonist (candesartan cilexetil) resulted in downregulation of MAPK activation as well as IL-6 release. The gene discussed is IL6; the disease is COVID-19.